Page 20 - 10 Booming Biotech Companies in India 2022
P. 20
SNAPSHOT
India’s Biotech sector is catego- Global Innovation Index amongst
rised into Biopharmaceuticals, Central & Southern Asia region.
BioIndustrial, Bioagriculture, BioIT &
BioServices. Within the biopharma- KEY POINTS
ceuticals segment, India has devel- • Forecast to reach $150 billion
oped into a prominent vaccine by 2025, with a CAGR of 16.4%
manufacturer globally, occupying a • 12.3% year on year growth
leading position in the supply DPT, ((FY19 to FY20)
BCG, and measles vaccines among • Over 5075+ biotech startups,
others. India also leads in biosimi- expected to reach 10,000 by 2025
lars, with one of the most biosim- • 760+ core biotech companies,
ilars approved in the domestic 200+ Biotech products
market. It is estimated that the • 38.1% CAGR for Biotech startup
biosimilars industry in India will growth over last seven Years.
grow at CAGR of 22% to become $ • 1Mn+ skilled biotech workforce
12 Bn by 2025. Within bio-services, • 100% FDI is allowed under the
, India offers a strong capability in automatic route for greenfield
contract manufacturing, research pharma.
and clinical trials, and is home • 100% FDI is allowed under the
to the most US FDA approved government route for brownfield
plants globally outside of the US. pharma in upto 74% FDI is under
The biotech industry in India automatic route and beyond 74%
comprises over 5,000 companies is under the government approval
(760 core companies and 4,240 route.
start-ups) 6 and is home to a strong • FDI up to 100% is allowed under
skilled resource pool due to the high the automatic route for the manu-
number of science and technology facturing of medical devices.
graduates. India is also ranked #1 SOURCE: Invest India
|20 thecorporatereview.com | India | Vol. 3 | Issue 4 | April 2022 |21
